Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer. [electronic resource]
Producer: 20200612Description: 3518-3527 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- therapeutic use
- Antigens, Neoplasm
- Antineoplastic Agents, Immunological -- therapeutic use
- Humans
- Immunoconjugates -- therapeutic use
- Male
- Middle Aged
- Oxidoreductases -- antagonists & inhibitors
- Prostatic Neoplasms, Castration-Resistant -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.